<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(10)</volume><submitter>Braila AD</submitter><pubmed_abstract>&lt;b>Background:&lt;/b> Endometrial proliferative lesions are common in the menopausal transition and carry a measurable risk of carcinoma. Early risk stratification may guide evaluation and follow-up. &lt;b>Methods:&lt;/b> We performed a single-center retrospective study of 315 women aged 45-55 years (May 2021-May 2024) at a private clinic in Bucharest. Lesions were classified per WHO 2014 as hyperplasia without atypia, atypical hyperplasia/endometrial intraepithelial neoplasia (AH/EIN), or adenocarcinoma; "advanced pathology" was defined as AH/EIN or adenocarcinoma. Clinical comorbidities and transvaginal ultrasound endometrial thickness were recorded. Associations were tested with χ&lt;sup>2&lt;/sup>; odds were estimated with multivariable logistic regression (adjusted ORs), with a modified Poisson sens</pubmed_abstract><journal>Clinics and practice</journal><pagination>177</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12563367</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Clinical and Histopathological Correlates of Endometrial Proliferative Lesions in Perimenopausal Women: A Retrospective Study with Internal Validation of a Risk Model.</pubmed_title><pmcid>PMC12563367</pmcid><pubmed_authors>Burcea A</pubmed_authors><pubmed_authors>Poalelungi CV</pubmed_authors><pubmed_authors>Braila AD</pubmed_authors><pubmed_authors>Damian CM</pubmed_authors><pubmed_authors>Albu CC</pubmed_authors><pubmed_authors>Cadar E</pubmed_authors><pubmed_authors>Tudor V</pubmed_authors><pubmed_authors>Bogdan-Andreescu CF</pubmed_authors><pubmed_authors>Banateanu AM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinical and Histopathological Correlates of Endometrial Proliferative Lesions in Perimenopausal Women: A Retrospective Study with Internal Validation of a Risk Model.</name><description>&lt;b>Background:&lt;/b> Endometrial proliferative lesions are common in the menopausal transition and carry a measurable risk of carcinoma. Early risk stratification may guide evaluation and follow-up. &lt;b>Methods:&lt;/b> We performed a single-center retrospective study of 315 women aged 45-55 years (May 2021-May 2024) at a private clinic in Bucharest. Lesions were classified per WHO 2014 as hyperplasia without atypia, atypical hyperplasia/endometrial intraepithelial neoplasia (AH/EIN), or adenocarcinoma; "advanced pathology" was defined as AH/EIN or adenocarcinoma. Clinical comorbidities and transvaginal ultrasound endometrial thickness were recorded. Associations were tested with χ&lt;sup>2&lt;/sup>; odds were estimated with multivariable logistic regression (adjusted ORs), with a modified Poisson sens</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-05-15T03:19:53.602Z</modification><creation>2026-05-15T03:12:14.849Z</creation></dates><accession>S-EPMC12563367</accession><cross_references><pubmed>41148775</pubmed><doi>10.3390/clinpract15100177</doi></cross_references></HashMap>